Sustainability in Injectable Drug Delivery Devices: A Systematic Literature Review of Environmental, Economic, and Public Health Impacts

Background:

Sustainable injectable drug delivery devices, such as prefilled syringes, multi-chamber syringes, and reusable systems, are gaining attention due to their potential to decrease resource use and waste. Despite these considerations, the integration of sustainability metrics into healthcare systems and pharmaceutical manufacturing is inconsistent, necessitating a systematic review of existing practices and outcomes.

Methods:

To address this gap, a systematic literature review (SLR) was conducted in June 2024, utilizing the databases of PubMed/MEDLINE and Embase. The studies were examined for sustainability outcomes related to environmental impact, economic efficiency, and public health benefits of injectable drug delivery systems. Cost adjustments were standardized to their respective 2024 currency along with U.S. dollars using price indices for the United States, United Kingdom, Netherlands, and Italy.

Results:

The literature search returned 2384 unique articles, with 24 studies meeting the inclusion criteria. The reviewed studies highlighted some of the potential benefits of sustainable injectable drug delivery devices. Environmental assessments reported reductions in waste and CO2 emissions, with examples from hospital implementations of prefilled syringes cutting waste by 26% to 86%, and modular insulin pumps showing a 44% increase in recycling efficiency compared to conventional systems. Economic evaluations revealed potential cost reductions of up to 26% of total drug expenditures, attributed to inefficient drug preparation processes and unused medications. Public health outcomes ranged from identified challenges in disposal practices to safer sustainable strategies, including a 57% reduction in hazardous waste that enhanced safety in a resource-limited setting. While the included studies varied in methodological rigor, most were rated as fair quality, with 2 studies rated as poor – indicating a need for more robust evidence to strengthen future evaluations.

Conclusion:

This review suggests that sustainable injectable drug delivery devices can reduce environmental impact, improve economic efficiency, and contribute to public health. By limiting waste, reducing carbon emissions, and supporting safety, these devices can offer measurable contributions for advancing sustainability in healthcare. However, the lack of clear sustainability standards and guidance from health systems and governments remains a key barrier to broader adoption.